Specialty	Neurology
Clinical Interests	Cerebrovascular Disease
	Stroke
	Neurology
Languages	English
	Spanish
Gender	Male
E-mail	steven.levine@mssm.edu
Education and Training	MD, Medical College of Wisconsin
	Residency, Neurology, University of Michigan Hospitals
	Internship, Internal Medicine, Mount Sinai Hospital
	Fellowship, Cerebrovascular Dis., Henry Ford Hospital
Awards	2003 Award for Bedside Teaching Mount Sinai Medical Center Department of Neurology
	2002 Top Physicians in Neurology Hour Magazine
	2002 - 2005 Top Doctors in New York (Neurology) New York Magazine
	2001 Teaching Award Wayne State University College
	2001 Excellence in Research Award for Physicians Blue Cross Blue Shield of Michigan Foundation
	1998 - 1999 Best Doctors in America Woodward/White, Inc.
	1997 Best Heart and Stroke Doctors Good Housekeeping Magazine
	1989 Twentythird Annual Harold G. Wolff, M.D. Lecture Award (co-recipient) American Association for the Study of Headache, for the paper
	1989 Second Annual Henry Ford Hospital
	1986 Twentieth Annual Harold G. Wolff, M.D. Lecture Award (co-recipient) American Association for the Study of Headache, for the paper
	1986 - 1987 Research Fellowship Award American Heart Association of Michigan
	1976 Alfred Poll Fellowship Award in Ophthalmology Research Albert Einstein College of Medicine
	1973 - 1977 Summa cum laude University of Michigan

Dr. Levine is a Professor of Neurology and Director of Cerebrovascular Education Program at The Mount Sinai Stroke Center. His research interests include thrombolytic therapies for acute ischemic stroke, the role of antiphospholipid antibodies in cerebrovascular disease, and the development of telemedicine systems for acute stroke management and treatment. He was a local principal investigator for the NIH funded NINDS rt-PA Stroke Trial that led to FDA approval of the first treatment for acute ischemic stroke " tissue plasminogen activator (tPA). His research has been NIH funded for the past 15 years (and has continued funding through June, 2008). He has actively trained stroke subspecialists (fellows) since 1987. He is the editor of the National Stroke Association's Stroke-Clinical Updates and serves on the Editorial Boards of Stroke, Neurology, Clinical Neuropharmacology, Seminars in Stroke and Cerebrovascular Disease, and Medlink.

Dr. Levine is a 1981 graduate of the Medical College of Wisconsin and served his residency in Neurology at the University of Michigan in Ann Arbor. He completed his subspecialty training in cerebrovascular diseases and stroke at the NIH-Designated Center for Stroke Research at the Henry Ford Health Science Center in Detroit, Michigan. He has previously served on the faculty of the University of Michigan, Case Western Reserve University (Detroit Campus), and Wayne State University.

He is an active consultant to the NIH/National Institute of Neurological Disorders and Stroke, American Heart/Stroke Association, and is a consultant to the pharmaceutical industry. He just finished a 4-year term reviewing training grants for the NIH (NINDS). He has published over 130 peer-reviewed articles, 42 invited contributions/reviews, 7 editorials, 50 book chapters, and 3 books in the field of stroke. He was an invited panelist for Acute Stroke Treatment: New Insights into Administering- A Live Interactive National Satellite Broadcast Conference conducted by the American Stroke Association in Chicago, Illinois. While in Detroit he conceived and implemented a comprehensive stroke risk assessment and prevention (STRAP) program.

Education and Training	MD, Medical College of Wisconsin
	Residency, Neurology, University of Michigan Hospitals
	Internship, Internal Medicine, Mount Sinai Hospital
	Fellowship, Cerebrovascular Dis., Henry Ford Hospital
Board Certification	Neurology

Specialty	Neurology
Clinical Interests	Cerebrovascular Disease
	Stroke
	Neurology
Languages	English
	Spanish
Board Certification	Neurology

The role of anti-beta-2-glycoprotein-I antibodies and antiphosphatidylserine antibodies in predicting recurrent stroke and thrombo-occlusive events following a first ischemic stroke.

Developing the application of telemedicine (real time video-audio telecommunications) to stroke (Telestroke).

The role of hemostatic markers in predicting hemorrhage, treatment response, and outcome following recombinant tissue plasminogen activator therapy for acute ischemic stroke.

Levine SR, Brust JC, Futrell N, Ho KL, Blake D, Millikan CH, Brass LM, Fayad P, Schultz LR, Selwa JF. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med 1990 Sep 13; 323(11): 699-704.

Levine SR, Gorman M. "Telestroke": the application of telemedicine for stroke. Stroke 1999 Feb; 30(2): 464-9.

Patel SC, Levine S, Tilley BC, Grotta JC, Lu M, Frankel M, Haley EC Jr, Brott TG, Broderick JP, Horowitz S, Lyden PD, Lewandowski CA, Marler JR, Welch KM. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001 Dec 12; 286(22): 2830-8.

Demchuk AM, Tanne D, Hill MD, Kasner SE, Hanson S, Grond M, Levine SR. Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology 2001 Aug 14; 57(3): 474-80.

Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002 Apr 9; 105(14): 1679-85.

Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, Murphy A, Lu Y, Costigan TM, Rhine C, Levin B, Triplett DA, Mohr JP. APASS Investigators. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004 Feb 4; 291(5): 576-84.

Schwamm LH, Rosenthal ES, Hirshberg A, Schaefer PW, Little EA, Kvedar JC, Petkovska I, Koroshetz WJ, Levine SR. Virtual TeleStroke support for the emergency department evaluation of acute stroke. Acad Emerg Med 2004 Nov; 11(11): 1193-7.

Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005 Mar 31; 352(13): 1305-16.

Demchuk AM, Hill MD, Barber PA, Silver B, Patel SC, Levine SR. for the NINDS rt-PA Stroke Study Group: Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 2005 Oct; 36(10): 2110-5.

Gorman MJ, Jacobs B, Sloan M, Roth Y, Levine SR. A web-based interactive database system for a transcranial Doppler ultrasound laboratory. Neuroimag 2006; 16: 1-5.